Correspondingly, functional studies using orthotopic xenograft models further confirmed that targeting IL‐8 improves sensitivity to docetaxel in both taxane‐sensitive and ‐resistant ovarian cancer cells.49 The gene discussed is CXCL8; the disease is ovarian carcinoma.